文献
J-GLOBAL ID:201802287425550365
整理番号:18A0611797
JAK3の薬理学的阻害はヒト慢性骨髄性白血病におけるイマチニブの抗腫瘍活性を増強する【Powered by NICT】
Pharmacological inhibition of JAK3 enhances the antitumor activity of imatinib in human chronic myeloid leukemia
著者 (5件):
Yagi Kenta
(Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, Japan)
,
Yagi Kenta
(Department of Clinical Pharmacy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, Okayama, Japan)
,
Shimada Akira
(Department of Pediatric Hematology/Oncology, Okayama University Hospital, Dentistry, 2-5-1 Shikata-cho, Kita-ku, Okayama, Japan)
,
Sendo Toshiaki
(Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, Japan)
,
Sendo Toshiaki
(Department of Clinical Pharmacy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, Okayama, Japan)
資料名:
European Journal of Pharmacology
(European Journal of Pharmacology)
巻:
825
ページ:
28-33
発行年:
2018年
JST資料番号:
B0841A
ISSN:
0014-2999
CODEN:
EJPHAZ
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)